Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Study: Ebola Vaccine May Fall Short

One of the Ebola vaccines about to enter testing in Liberia may not be as potent as researchers had hoped, according to a new study, raising questions about how well it will prevent infection. The vaccine, developed by GlaxoSmithKline, is one of two in a large-scale clinical trial expected to begin in the next two weeks. Merck produced the other vaccine. Earlier studies had found that one dose of the GSK vaccine would protect monkeys from Ebola. However, in the study published in...

Read complete article
© Voice of America -

Follow us on ...
Facebook Twitter